Milestone Pharmaceuticals Inc. (MIST) Net income 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$63,058FY2025 · since FY2018: -$23.2M → -$63,058
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63,058 | -51.9% |
| FY2024 | -$41,519 | +30.4% |
| FY2023 | -$59,685 | +99.9% |
| FY2022 | -$58.4M | -36.3% |
| FY2021 | -$42.9M | +14.2% |
| FY2020 | -$50.0M | +9.5% |
| FY2019 | -$55.2M | -138.2% |
| FY2018 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice